<DOC>
	<DOC>NCT02234843</DOC>
	<brief_summary>The purpose of this study is to evaluate comparative efficacy and safety of rivaroxaban to standard of care in children with acute venous thromboembolism.</brief_summary>
	<brief_title>EINSTEIN Junior Phase III: Oral Rivaroxaban in Children With Venous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Children aged 6 months to &lt; 18 years with confirmed venous thromboembolism who receive initial treatment with therapeutic dosages of UFH (unfractionated Heparin), LMWH (low molecular weight heparin) or fondaparinux and require anticoagulant therapy for at least 90 days Active bleeding or bleeding risk contraindicating anticoagulant therapy An estimated glomerular filtration rate (eGFR) &lt; 30 mL/min/1.73 m*2 Hepatic disease which is associated with either: coagulopathy leading to a clinically relevant bleeding risk, or ALT&gt; 5x upper level of normal (ULN) or total bilirubin &gt; 2x ULN with direct bilirubin &gt; 20% of the total Platelet count &lt; 50 x 10*9/L Sustained uncontrolled hypertension defined as &gt; 95th age percentile Life expectancy &lt; 3 months Concomitant use of strong inhibitors of both cytochrome P450 isoenzyme 3A4 (CYP3A4) and Pglycoprotein (Pgp), including but not limited to all human immunodeficiency virus protease inhibitors and the following azole antimycotics agents: ketoconazole, itraconazole, voriconazole, posaconazole, if used systemically Concomitant use of strong inducers of CYP3A4, including but not limited to rifampicin, rifabutin, phenobarbital, phenytoin and carbamazepine Childbearing potential without proper contraceptive measures, pregnancy or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pediatric</keyword>
</DOC>